CORRELATION BETWEEN CLINICAL MANIFESTATIONS OF OSTEOARTHRITIS AND FLUCTUATING BLOOD LEVELS OF INTERLEUKIN 6
https://doi.org/10.14412/1995-4484-2012-1178
Abstract
Objective — to evaluate associations between fluctuating interleukin 6 (IL6) levels and clinical manifestations of osteoarthritis (OA). Material and methods. Totally 81 patients aged 47—73 y.o. with OA diagnosis, meeting ACR criteria, were evaluated. Anthropometric measurements, duration of the disease, degree of functional disability, IL6 levels and joints radiographs were assessed in all patients. Correlation between different IL6 secretion levels and the severity of OA clinical course and of pain syndrome was also analyzed. Results and discussion. Elevated IL6 levels were associated with more pronounced radiographic structural damage, greater degree of functional disability, presence of synovitis and more severe pain syndrome. Therefore, elevated IL6 levels are associated with unfavorable clinical course of OA.
References
1. <div><p>Фоломеева О.М., Эрдес Ш.Ф. Распространенность и социальная значимость ревматических заболеваний в Российской Федерации. Науч.-практич. ревматол. 2007; 4: 4-9.</p><p>Рациональная фармакотерапия ревматических заболеваний: Рук-во для практикующих врачей. М.: Литтерра, 2003; 3: 143-53.</p><p>Smith M.M., Ghosh P. Osteoarthritis: Current status and future direction. APLAR J Rheum 2008; 2: 27-53.</p><p>Heinrich P.C., Castell J.V., Andus T. Interleukin 6 and the acute phase response. Biochem J 2006; 265: 621-36.</p><p>Altman R., Alarcon G., Appelrouth D. et al. The American College of Reumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthr Rheum 1991; 34: 505-14.</p><p>Букина И.Е. Синовит и кисты Бейкера на разных стадиях остеоартроза. Cons Med 2003; 5(2): 546—8.</p><p>Ревматология: Национальное руководство. Под ред. Е.Л. Насонова, В.А. Насоновой. М.: ГЭОТАР-Медиа, 2008; 573—88.</p><p>Garnero P., Delmas P.D. Biomarkers in osteoarthritis. Curr Opin Rheum 2003; 15(5): 641—6.</p><p>Алексеенко Е.Ю., Говорин А.В. Оценка маркеров воспаления и показателей оксидативного стресса у больных остеоартрозом в сочетании с артериальной гипертензией. Сиб. мед. журн. 2011; 1: 54-7.</p><p>Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin 6 family of cytokines and gp130. Blood 2005; 86: 1243-54.</p><p>McGee D.W., Beagley K.W., Aicher W.K., McGhee J.R. Transforming growth factor-beta and IL-1 beta act in synergy to enhance IL 6 secretion by the intestinal epithelial cell line, IEC-6. J Immunol 2003; 151: 970-8.</p><p>Schindler R., Mancilla J., Endres S. et al. Correlations and interactions in the production of interleukin 6 (IL 6), IL 1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL 6 suppresses IL 1 and TNF. Blood 2000; 75: 40-7.</p></div><br />
Review
For citations:
Kopylova D.A., Ostapenko V.A. CORRELATION BETWEEN CLINICAL MANIFESTATIONS OF OSTEOARTHRITIS AND FLUCTUATING BLOOD LEVELS OF INTERLEUKIN 6. Rheumatology Science and Practice. 2012;50(5):34-36. (In Russ.) https://doi.org/10.14412/1995-4484-2012-1178
Views:
918
Email this article 